Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Omicron (B.1.1.529) variant of SARS‐CoV‐2: Concerns, challenges, and recent updates
Ranjan K. Mohapatra, Ruchi Tiwari, Ashish K. Sarangi, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 6, pp. 2336-2342
Open Access | Times Cited: 82

Showing 51-75 of 82 citing articles:

Role of available COVID-19 vaccines in reducing deaths and perspective for next generation vaccines and therapies to counter emerging viral variants: an update
Mohd Wahid, Arshad Jawed, Raju K. Mandal, et al.
Minerva Medica (2023) Vol. 114, Iss. 5
Closed Access | Times Cited: 7
Chinese University Students’ Awareness and Acceptance of the COVID-19 Vaccine: A Cross-Sectional Study
Shirui Li, Zhihui Gao, Meihan Zhong, et al.
Risk Management and Healthcare Policy (2022) Vol. Volume 15, pp. 845-864
Open Access | Times Cited: 11
Decreasing trend of monkeypox cases in Europe and America shows hope for the world: Evidence from the latest epidemiological data
Md. Robin Khan, Md. Jamal Hossain, Arpita Roy, et al.
Health Science Reports (2022) Vol. 6, Iss. 1
Open Access | Times Cited: 11
Community‐based decentralized mental health services are essential to prevent the epidemic turn of post‐Covid mental disorders in Bangladesh: A call to action
Md. Rabiul Islam, Mohammad Saydur Rahman, MMA Shalahuddin Qusar
Health Science Reports (2022) Vol. 5, Iss. 4
Open Access | Times Cited: 10
The Upsurge of Diarrhea Amid COVID-19 Pandemic Makes Matter Worse in Bangladesh: A Call to Action
Smaranika Rahman, Md. Jamal Hossain, Md. Rabiul Islam
Gerontology and Geriatric Medicine (2022) Vol. 8, pp. 233372142211174-233372142211174
Open Access | Times Cited: 9
Comparative genomics, evolutionary epidemiology, and RBD-hACE2 receptor binding pattern in B.1.1.7 (Alpha) and B.1.617.2 (Delta) related to their pandemic response in UK and India
Chiranjib Chakraborty, Ashish Ranjan Sharma, Manojit Bhattacharya, et al.
Infection Genetics and Evolution (2022) Vol. 101, pp. 105282-105282
Open Access | Times Cited: 8
Older age and depressive state are risk factors for re-positivity with SARS-CoV-2 Omicron variant
Maojun Li, Huawen Peng, Guangyou Duan, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 8
Evaluating Data Sharing of SARS-CoV-2 Genomes for Molecular Epidemiology across the COVID-19 Pandemic
Teresa Rito, Pedro Fernandes, Raquel Duarte, et al.
Viruses (2023) Vol. 15, Iss. 2, pp. 560-560
Open Access | Times Cited: 4
Comparative Performance Evaluation of Personal Protective Measures and Antiviral Agents Against SARS-CoV-2 Variants: A Narrative Review
Md. Anamul Haque, Md. Tanbir, Bulbul Ahamed, et al.
Clinical Pathology (2023) Vol. 16
Open Access | Times Cited: 4
SARS‐CoV‐2 neutralising antibody therapies: Recent advances and future challenges
Mingtao Liu, Zhiman Liang, Zhangkai J. Cheng, et al.
Reviews in Medical Virology (2023) Vol. 33, Iss. 5
Closed Access | Times Cited: 4
Omicron variant losing its critical mutations in the receptor‐binding domain
Perumal Arumugam Desingu, K. Nagarajan
Journal of Medical Virology (2022) Vol. 94, Iss. 6, pp. 2365-2368
Open Access | Times Cited: 7
The Inhibitory Potential of Ferulic Acid Derivatives against the SARS-CoV-2 Main Protease: Molecular Docking, Molecular Dynamics, and ADMET Evaluation
Io Antonopoulou, Eleftheria Sapountzaki, Ulrika Rova, et al.
Biomedicines (2022) Vol. 10, Iss. 8, pp. 1787-1787
Open Access | Times Cited: 7
SARS-CoV-2 omicron variant clearance delayed in breakthrough cases with elevated fasting blood glucose
Xiujun Zhang, Guocan Si, Huifen Lu, et al.
Virology Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 7
Knowledge, acceptance and perception about COVID-19 vaccines in Bangladesh: Findings from a web-based cross-sectional study
Md. Sakhawat Hossain, Md. Rabiul Islam, Mohammad Touhidul Islam, et al.
Open Health (2022) Vol. 3, Iss. 1, pp. 73-86
Open Access | Times Cited: 6
Omicron: Understanding the Latest Variant of SARS‐CoV‐2 and Strategies for Tackling the Infection
Sreekanth Reddy Obireddy, Ujwala Guntakanti, Kowthalam Anitha, et al.
ChemBioChem (2022) Vol. 23, Iss. 14
Open Access | Times Cited: 5
Epidemiological Characterization of Patients in the First Eight Weeks Following Detection of SARS-CoV-2 B.1.1.529 (omicron) Variant in Cuba
Lissette Pérez-Santosa, Vivian Kourí-Cordellá, María Guadalupe Guzmán-Tiradoa, et al.
MEDICC Review (2022) Vol. 24, Iss. 3–4, pp. 18-18
Open Access | Times Cited: 5
COVID-19 Omicron variant - Time for airborne precautions
Zohaib Yousaf, Muhammad Arslan Khan, Muhammad Sohaib Asghar, et al.
Annals of Medicine and Surgery (2022) Vol. 78
Open Access | Times Cited: 4
Molecular Epidemiology of Omicron CH.1.1 Lineage: Genomic and Phenotypic Data Perspective
Yasir Mohammed A. Al Qurashi, Jawaher A. Abdulhakim, Samia S. Alkhalil, et al.
Cureus (2024)
Open Access
COVID-19 and patients on renal replacement therapy: Perspective from the State of Qatar
Abdullah Hamad, Mohamad M. Alkadi, Hassan A. Al‐Malki
Qatar medical journal (2024) Vol. 2024, Iss. 1
Open Access
Genetic analysis of SARS-CoV-2 spike gene using next generation sequencing from COVID-19 patients in Erbil/Iraq
Asma Ameen Ghareeb, Sazan Moffaq Abdulaziz
Cellular and Molecular Biology (2024) Vol. 70, Iss. 6, pp. 7-13
Open Access
Exploring the potential of FDA approved anti-diabetic drugs for repurposing against COVID-19: a core combination of multiple computational strategies and integrated artificial intelligence
Nusrat Shafiq, Aqsa Jannat, Huma Munir, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 13, pp. 6556-6576
Closed Access | Times Cited: 1
From past to present: Exploring COVID-19 in Qatar’s hemodialysis population across Omicron dominant and pre-Omicron periods
Abdullah Hamad, Musab Elgaali, Tarek A. Ghonimi, et al.
PLoS ONE (2023) Vol. 18, Iss. 9, pp. e0291266-e0291266
Open Access | Times Cited: 1
Multi-faceted analysis of COVID-19 epidemic in the Republic of Korea considering Omicron variant: Mathematical modeling-based study
Youngsuk Ko, Victoria Mendoza, Renier Mendoza, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 2
SARS-CoV-2 Omicron variant: exploring healthcare workers’ awareness and perception of vaccine effectiveness: a national survey during the first week of WHO variant alert
Mohamad‐Hani Temsah, Fadi Aljamaan, Shuliweeh Alenezi, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 2
A Global Analysis of the Effectiveness of Policy Responses to COVID-19
Kwadwo Agyapon-Ntra, Patrick McSharry
Research Square (Research Square) (2022)
Open Access | Times Cited: 1

Scroll to top